Researchers within the Penn Pancreatic Cancer Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress.
This paper in Genetics in Medicine is a collaborative effort between Penn Medicine, the Basser Center, and researchers across the country. It is the first large-scale report on the CTNNA1 gene, which may represent a risk factor for early-onset gastric cancer and possibly breast cancer.
The Jewish Exponent highlights the BFOR Study, which offers no-cost testing to men and women of Ashkenazi Jewish descent for BRCA gene mutations. Basser Executive Director Susan Domchek, MD, a principal investigator on the study, notes that the Philadelphia area is still open for enrollment.
Lilith Magazine examined the genetic risk of ovarian cancer, especially in Jewish women, and interviewed Basser Executive Director Susan Domchek, MD, about prevention, screening, and treatment options.
Susan Domchek, MD, Executive Director of the Basser Center, discussed at-home genetic testing and whether or not patients who need these tests the most have access.
Wall Street Journal
In a letter to the editor in the Wall Street Journal, Basser’s Kara Maxwell, MD, PhD, and Susan Domchek, MD, responded to an article the paper recently published about genetic testing, pointing out that reinterpretation of a patient’s genetic testing results is an incredibly rare case.
Cancer Today interviewed Susan Domchek, MD, Executive Director of the Basser Center, about BRCA screening, who should get tested, and who is being left out under current guidelines.
In this editorial for Nature, Basser Executive Director Susan Domchek, MD, discusses genetic testing and breast cancer - which patients should be tested and what genetic mutations they should be tested for.
Payal D. Shah, MD, an assistant professor of Hematology-Oncology at Penn Medicine and a member of the Basser Center, spoke about new treatments that are letting people live longer and improving quality of life for some patients with metastatic breast cancer.
Experts from Penn Medicine's Abramson Cancer Center, including Basser Genetic Counselor Dana Farengo Clark, MS, LCGC, answered questions about cancer from NBC10 Philadelphia viewers as part of a telethon in partnership with the American Association for Cancer Research.
New guidelines from USPSTF on BRCA genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk, according to critics of the update, including Basser’s Susan Domchek, MD.
The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers.
Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD.
Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINX & BRCA, an initiative to raise awareness of hereditary cancer in the Latinx community.
Basser Executive Director Susan Domchek, MD, commented on Congressional candidate Maya Rockeymore Cummings’ decision to undergo a preventive double mastectomy based on her family history of cancer.
2019 represents a specific milestone in the fight. It’s been 25 years since the BRCA1 gene was first cloned — a discovery that accelerated cancer research and opened a new path for exploration in cancer prevention and treatment.
New York Times
Basser Young Leadership Council co-chair Erika Stallings writes for The New York Times about the importance of genetic testing for African Americans.